Legend Biotech earnings were -$218.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest LEGN earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$100.9M, down 483.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LEGN reported annual earnings of -$177.0M, with -65.8% growth.
On LEGN's earnings call on Invalid Date, Legend Biotech (NASDAQ: LEGN) reported Q1 2025 earnings per share (EPS) of -$0.54, up 68.75% year over year. Total LEGN earnings for the quarter were -$100.92 million. In the same quarter last year, Legend Biotech's earnings per share (EPS) was -$0.32.
As of the last Legend Biotech earnings report, Legend Biotech is currently losing money. Legend Biotech's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$218.15 million, a 53.18% decrease year over year.
What was LEGN's earnings growth in the past year?
As of Legend Biotech's earnings date in Invalid Date, Legend Biotech's earnings has grown year over year. LEGN earnings in the past year totalled -$218.15 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.